Alerts will be sent to your verified email
Verify EmailEUROASIA
|
RRP Defense
|
Remus Pharmaceutical
|
TVS Electronics
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
13.57 % | 22.94 % | 10.8 % |
|
5yr average Equity Multiplier
|
3.11 | 1.87 | 5.32 |
|
5yr Average Asset Turnover Ratio
|
2.25 | 1.12 | 6.56 |
|
5yr Avg Net Profit Margin
|
4.67 % | 11.07 % | 0.53 % |
|
Price to Book
|
71.69 | 0.0 | 9.72 |
|
P/E
|
0.0 | 25.29 | 740.83 |
|
5yr Avg Cash Conversion Cycle
|
-49.22 Days | 37.04 Days | -6.65 Days |
|
Inventory Days
|
8.89 Days | 36.45 Days | 25.51 Days |
|
Days Receivable
|
193.0 Days | 65.7 Days | 28.22 Days |
|
Days Payable
|
83.72 Days | 111.91 Days | 46.4 Days |
|
5yr Average Interest Coverage Ratio
|
48.61 | 48.28 | 12.69 |
|
5yr Avg ROCE
|
22.53 % | 25.27 % | 18.58 % |
|
5yr Avg Operating Profit Margin
|
3.61 % | 14.8 % | 2.04 % |
|
5 yr average Debt to Equity
|
0.54 | 0.19 | 0.46 |
|
5yr CAGR Net Profit
|
n/a | 27.88 % | 34.0 % |
|
5yr Average Return on Assets
|
2.92 % | 12.5 % | 2.71 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
74.65 % | 70.95 % | 59.77 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
58.47 % | 1.34 % | -0.14 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
RRP Defense
|
Remus Pharmaceutical
|
TVS Electronics
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|